The first layer is driven by the loss of the PTEN tumor suppressor or the activation of the PI3K pathway, which leads to β-catenin activation, Tcra/d-Myc translocation and T-ALL development. The gene discussed is PTEN; the disease is acute lymphoblastic leukemia.